ASML's Order Book Runs to 2028, but Washington's Latest China Gambit Casts a Long Shadow

ASML shares drift sideways amid reports of a potential US-led export ban to China, while technicals show consolidation within an uptrend.

The Dutch lithography giant finds itself squeezed between two powerful forces: an order pipeline that stretches years into the future and a geopolitical squeeze that could sever one of its most important revenue streams. For investors, the tension has produced a stock that is neither crashing nor soaring — it is simply marking time.

The China Question Takes a New Turn

A report from TechPowerUp, citing Dutch news service NU, suggested over the weekend that Washington is pressing The Hague to compel ASML to halt nearly all exports of chip-manufacturing equipment to China. That would represent a significant escalation from current restrictions, which have largely targeted the most advanced EUV systems and, to a degree, DUV tools. A comprehensive ban would sweep in a far broader array of machine types and put a substantial chunk of ASML's China revenue at risk.

Crucially, this remains a report of possible political intentions rather than a decided policy. Whether the Dutch government bends to American pressure is an open question, and the coming weeks in both Den Haag and Washington will likely determine the trajectory. For ASML, whose operations are deeply intertwined with Asian chipmakers, this is no peripheral concern — though the company has spent years diversifying its China exposure, the country remains a major market.

A Technical Pause After a Powerful Run

The market's response so far has been measured. The stock closed Tuesday at €1,496.80, up 0.3 percent on the day, though down 0.4 percent on the week. That sideways drift suggests investors are treating the China headlines with caution rather than alarm.

The picture looks similar across other timeframes. A separate assessment put Tuesday's close at €1,495.80, a 0.2 percent gain, with a 0.5 percent weekly decline and a 30-day trend still positive at 2.5 percent. (The slight discrepancy between the two figures reflects different closing data points.) Either way, the stock sits roughly 3.5 percent below its 50-day moving average while remaining comfortably above the 200-day average — the classic signature of consolidation within an uptrend.

The technical indicators tell a consistent story. The relative strength index reads 46.5, neither overbought nor oversold, leaving room for movement in either direction. The stock trades about 14 percent below its 52-week high of €1,748.00, reached on June 30. And while the year-to-date gain of 62 percent underscores the strength of the broader rally, the recent weeks have clearly been a period of digestion rather than acceleration.

Back on August 20, market observers had already noted that ASML was pulling back for a second consecutive session after a two-week rally, testing a key chart level. That pattern reads more like a healthy breather than a trend reversal — a view supported by the stock's position relative to its longer-term averages.

Why the Order Book Matters Now

In a sector where sentiment can turn on a headline, ASML offers something many peers cannot: visibility that extends well beyond the current year. A Seeking Alpha comparison on Monday pitted ASML directly against wafer-fab equipment maker KLA, concluding that only ASML remains buyable at current levels. The reasoning: ASML's order books are already filled for 2027 and 2028, its earnings revisions are stronger, and its business is simply less cyclical than the competition. KLA may boast higher near-term growth, but that momentum is already priced into the shares.

That distinction cuts to the heart of what investors are asking about every semiconductor stock these days: how much of the growth is already reflected in the price, and how much still lies ahead? ASML's multi-year order coverage suggests a good portion of the substance has yet to be consumed — a contrast with names whose rallies are heavily dependent on near-term AI hype.

The fundamental picture supports the patience. The company's operational performance has been robust, the High-NA EUV business is ramping, and Intel Foundry began high-volume manufacturing of selected processors using ASML equipment back in July. The share buyback program announced on January 28 continues to run, with further transactions reported on August 24 — typically a signal of management confidence in the company's valuation, even if it does nothing to resolve the geopolitical overhang.

A Sector on Edge

The broader environment does little to calm nerves. One prominent chip analyst has warned of a potential further 10 percent decline in the semiconductor group, while Goldman Sachs describes the current trading dynamic between chips and software as a historic "photographic negative" — long semiconductors, short software.

Geopolitical frictions are compounding the sector's jitters. Nvidia's China revenue halved in the second quarter, and Taiwan has indicted nine individuals over illegal server exports. Multinationals are increasingly forced to navigate between competing US and Chinese sanctions and export controls, with consequences for supply chains and market certainty.

Yet the demand picture beneath the political noise remains intact. SK Hynix and Samsung are aggressively expanding fab capacity in Dalian and Xi'an, underscoring that the appetite for advanced lithography equipment is undiminished — regardless of how the export rules are ultimately written.

The Balancing Act

For ASML, the structural arguments remain compelling. An order book that runs to 2028 is a rare commodity in a sector currently rattled by valuation concerns and export risks. The recent share price weakness looks more like a technical digestion phase after a powerful rally than the end of the story.

But the China question is not going away. Should the reported US push actually crystallize into concrete policy, it would strike at one of the few remaining growth pillars for the company. For now, the stock sits in a holding pattern — supported by fundamentals that few competitors can match, yet constrained by a political risk that no amount of order-book visibility can fully neutralize. Investors would be wise to keep one eye on the technicals and the other on The Hague.